Toxicities Associated with PARP Inhibitors in Ovarian Cancer

Video

Ursula A. Matulonis, MD, professor of Medicine, Harvard Medical School, medical director of Gynecologic Oncology, Dana-Farber Cancer Institute, discusses the toxicities that are associated with PARP inhibitors in ovarian cancer.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos